4//SEC Filing
ALTSCHULLER Susan 4
Accession 0000950170-23-026503
CIK 0001805387other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 8:15 PM ET
Size
7.9 KB
Accession
0000950170-23-026503
Insider Transaction Report
Form 4
ALTSCHULLER Susan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-06-01+124,168→ 124,168 totalExercise: $32.55Exp: 2033-06-01→ Common Stock (124,168 underlying) - Award
Restricted Stock Units
2023-06-01+30,721→ 30,721 total→ Common Stock (30,721 underlying)
Footnotes (3)
- [F1]25% of this option shall vest and become exercisable on June 1, 2024, with the remainder vesting in thirty-six (36) monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F2]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock.
- [F3]The RSUs vest in four equal annual installments on each of June 1, 2024, June 1, 2025, June 1, 2026 and June 1, 2027, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001817988
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 8:15 PM ET
- Size
- 7.9 KB